Improving management of needle distress during the journey to dialysis through psychological education and training-the INJECT study feasibility pilot protocol.
Education
Haemodialysis
Needle distress
Psychology
Training
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
04 Feb 2022
04 Feb 2022
Historique:
received:
02
06
2021
accepted:
20
01
2022
entrez:
5
2
2022
pubmed:
6
2
2022
medline:
6
2
2022
Statut:
epublish
Résumé
Needle-related distress is a common yet poorly recognised and managed problem among haemodialysis (HD) patients. The aim of this pilot study is to test the feasibility and acceptability of the INJECT Intervention-an innovative psychology-based intervention to empower patients to self-manage needle distress with the support of dialysis nurses. This investigator-initiated, single-arm, non-randomised feasibility study will take place in a large dialysis service in Adelaide, Australia. Participants will include patients aged ≥ 18 years, commencing or already receiving maintenance HD, recruited through dialysis physicians and nursing staff as individuals believed to be at risk of needle distress. They will be screened for inclusion using the Dialysis Fear of Injection Questionnaire (DFIQ) and enrolled into the study if the score is ≥ 2. The multi-pronged intervention encompasses (i) psychologist review, (ii) patient self-management program and (iii) nursing education program. The primary aim is to evaluate feasibility and acceptability of the intervention from patient and dialysis nurse perspectives, including recruitment, retention, engagement with the intervention and completion. Secondary exploratory outcomes will assess suitability of various tools for measuring needle distress, evaluate acceptability of the nursing education program and measure cannulation-related trauma and vascular access outcomes. The results will inform the protocol for larger trials addressing needle distress in HD patients. Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12621000229875, approved 4 April 2021, https://www.anzctr.org.au/ .
Sections du résumé
BACKGROUND
BACKGROUND
Needle-related distress is a common yet poorly recognised and managed problem among haemodialysis (HD) patients. The aim of this pilot study is to test the feasibility and acceptability of the INJECT Intervention-an innovative psychology-based intervention to empower patients to self-manage needle distress with the support of dialysis nurses.
METHODS
METHODS
This investigator-initiated, single-arm, non-randomised feasibility study will take place in a large dialysis service in Adelaide, Australia. Participants will include patients aged ≥ 18 years, commencing or already receiving maintenance HD, recruited through dialysis physicians and nursing staff as individuals believed to be at risk of needle distress. They will be screened for inclusion using the Dialysis Fear of Injection Questionnaire (DFIQ) and enrolled into the study if the score is ≥ 2. The multi-pronged intervention encompasses (i) psychologist review, (ii) patient self-management program and (iii) nursing education program. The primary aim is to evaluate feasibility and acceptability of the intervention from patient and dialysis nurse perspectives, including recruitment, retention, engagement with the intervention and completion. Secondary exploratory outcomes will assess suitability of various tools for measuring needle distress, evaluate acceptability of the nursing education program and measure cannulation-related trauma and vascular access outcomes.
CONCLUSION
CONCLUSIONS
The results will inform the protocol for larger trials addressing needle distress in HD patients.
TRIAL REGISTRATION
BACKGROUND
Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12621000229875, approved 4 April 2021, https://www.anzctr.org.au/ .
Identifiants
pubmed: 35120560
doi: 10.1186/s40814-022-00989-2
pii: 10.1186/s40814-022-00989-2
pmc: PMC8815234
doi:
Types de publication
Journal Article
Langues
eng
Pagination
28Subventions
Organisme : Royal Adelaide Hospital Research Committee
ID : My IP 12879
Informations de copyright
© 2022. The Author(s).
Références
Semin Dial. 2020 Nov;33(6):457-463
pubmed: 33030298
Cochrane Database Syst Rev. 2018 Oct 04;10:CD005179
pubmed: 30284240
J Med Internet Res. 2019 Nov 12;21(11):e13540
pubmed: 31714251
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Kidney Int. 2009 Aug;76(4):414-21
pubmed: 19455196
Health Expect. 2014 Oct;17(5):710-23
pubmed: 22748072
J Ren Care. 2021 Sep;47(3):193-207
pubmed: 33491276
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Dialogues Clin Neurosci. 2015 Sep;17(3):337-46
pubmed: 26487814
BMJ Open. 2017 Feb 17;7(2):e013537
pubmed: 28213598
Pain Med. 2018 Jan 1;19(1):151-159
pubmed: 29025113
Annu Rev Psychol. 2006;57:285-315
pubmed: 16318597
Acta Biomed. 2018 Feb 21;89(4-S):55-63
pubmed: 29644990
Nephrol Dial Transplant. 2011 Oct;26(10):3302-8
pubmed: 21406543
J Ren Care. 2013 Dec;39(4):214-21
pubmed: 24164793
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):401-408
pubmed: 29657210
Eur J Pediatr. 2021 Mar;180(3):725-731
pubmed: 32779029
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
J Vasc Access. 2021 Sep;22(5):726-732
pubmed: 32912057
BMJ Open. 2016 Apr 12;6(4):e011286
pubmed: 27072573
Cochrane Database Syst Rev. 2013 Oct 10;(10):CD005179
pubmed: 24108531
Nephrol Dial Transplant. 2020 May 1;35(5):755-764
pubmed: 32240311
Am J Kidney Dis. 2003 Feb;41(2):380-5
pubmed: 12552500
Kidney Int. 2018 Dec;94(6):1053-1068
pubmed: 30360959
JAMA Surg. 2015 Aug;150(8):764-70
pubmed: 26107005
J Am Soc Nephrol. 2014 Jan;25(1):196-206
pubmed: 24115478
J Adv Nurs. 2019 Jan;75(1):30-42
pubmed: 30109720
Hemodial Int. 2019 Jul;23(3):285-286
pubmed: 30861295
Int J Clin Pract. 2007 Mar;61(3):453-7
pubmed: 17313613
Clin J Pain. 2015 Oct;31(10 Suppl):S109-23
pubmed: 26352916
Behav Cogn Psychother. 2009 Jan;37(1):61-72
pubmed: 19364408
J Consult Clin Psychol. 2015 Dec;83(6):1108-22
pubmed: 26302248
PLoS One. 2021 Jun 10;16(6):e0253048
pubmed: 34111207
Lancet. 2017 Dec 17;388(10063):3048-3059
pubmed: 27349358